Global Muscle Relaxant Drugs Market 2017-2021

Table of Contents

PART 01: Executive summary

PART 02: Scope of  the report

PART 03: Research Methodology

PART 04: Introduction

• Key market highlights

PART 05: An overview of muscle spasticity and spasms

PART 06: Pipeline landscape

PART 07: Market landscape

• Market overview
• Five forces analysis

PART 08: Market segmentation by product category

• Skeletal muscle relaxant drugs
• Facial muscle relaxant drugs

PART 09: Geographical segmentation

• Muscle relaxant drugs market in Americas
• Muscle relaxant drugs market in EMEA
• Muscle relaxant drugs market in APAC

PART 10: Decision framework

PART 11: Drivers and challenges

• Market drivers
• Impact of drivers on key customer segments
• Market challenges
• Impact of challenges on key customer segments

PART 12: Market trends

• Anti-aging treatments driving adoption of facial relaxants
• Advanced drug delivery technologies fuels adoption of muscle relaxants
• Growing use of muscle relaxants in new indications and applications

PART 13: Vendor landscape

• Competitive scenario

PART 14: Key vendor analysis

• Pfizer
• Allergan
• Ipsen Group
• Teva Pharmaceuticals
• Novartis
• Other prominent vendors

PART 15: Appendix

• List of abbreviations